Beijing, China

Yingxi Tai

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Boe Technology Group Co., Ltd., Hefei Boe Optoelectronics Technology Co., Ltd.. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yingxi Tai - Innovator in Medical Technology

Introduction

Yingxi Tai is a prominent inventor based in Beijing, China. She has made significant contributions to the field of medical technology, particularly in the area of blood vessel detection. Her innovative approach combines advanced sensor technology with processing capabilities to enhance medical diagnostics.

Latest Patents

Yingxi Tai holds a patent for a "Device for determining location of blood vessel and method thereof." This invention includes a plurality of sensors that detect pressure values at various skin locations. The processor determines the location of the blood vessel based on these pressure values. The device is designed to indicate the location of the blood vessel, which is crucial for medical procedures.

Career Highlights

Throughout her career, Yingxi Tai has worked with notable companies such as Hefei Boe Optoelectronics Technology Co., Ltd. and BOE Technology Group Co., Ltd. Her experience in these organizations has allowed her to develop and refine her innovative ideas in medical technology.

Collaborations

Yingxi Tai has collaborated with talented individuals in her field, including Qiangqiang Luo and Haitao Wang. These partnerships have contributed to her success and the advancement of her inventions.

Conclusion

Yingxi Tai is a remarkable inventor whose work in medical technology has the potential to improve patient care significantly. Her dedication to innovation and collaboration continues to drive advancements in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…